The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShanghai Changzheng Hospital
About this trial
The aim of this clinical study is to explore the impact of whether radiotherapy is administered after spinal metastasis surgery on the prognosis and survival of patients, to describe the clinical outcomes, and to optimize future clinical decisions.
Eligibility criteria
Qualifiers
Age over 18 years old, gender not limited;
The patient has undergone separation surgery within 3 weeks;
The pathological result of the separation surgery site of the patient indicates that the lesion is a metastatic tumor, and the primary lesion is located outside the spine;
The expected survival period is ≥ 6 months;
Disqualifiers
Patients with poor general condition and those who are intolerant to radiotherapy, chemotherapy, and targeted therapy;
Patients whose treatment segments have not received any other surgical treatment or radiotherapy;
Patients who participated in other clinical trials of drugs or medical devices within 3 months before enrollment;
Other situations judged by the investigator as making the subject unsuitable for enrollment.
Trial design
Treatments tested in this trial
- radiotherapy
Treatment groups
130 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov